 TherapeuticsMD, Inc. NASDAQ:TXMD Q2 2022 Earnings Conference Call August 15, 2022 8:30 PM ET Company Participants Lisa Wilson - IR Hugh ODowd - CEO Michael Donegan - Interim CFO Mark Glickman - Chief Commercial Officer Conference Call Participants Douglas Tsao - H.C. Wainwright Operator Starts Abruptly for the Therapeutics MDs Second Quarter 2022 Financial Results Conference Call. 